Vaccine and treatment evaluation units (vteu) protocol development, implementation and assays task area b-d population pharmacokinetic analyses task order 16-0075.B2C2D2.0053
Ended Awarded Last action
- Contract number
- HHSN27200017
- Awardee
-
University Of Maryland, Baltimore UEI Z9CRZKD42ZT1 Part of University System Of Maryland
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,468,838
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (vteu) Award Notice · Posted Mar 29, 2012
- Contract value 83% obligated
-
- $1,468,837.55 Current, with exercised options
- $1,771,855.55 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Baltimore, MD 21201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,433 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | -$553,944 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $302,123 | |
| Exercise an Option | $324,406 | |
| Original award | $1,397,685 |
About this award
This is a delivery order awarded to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) contract vehicle, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The task order, valued at $1,771,855.55, is for vaccine and treatment evaluation protocol development, implementation, and assays, as well as population pharmacokinetic analyses. UMB, as the prime contractor, will leverage its expertise and facilities to support this work. The contract does not utilize any set-aside designations. As a center within the University System of Maryland (USM), UMB regularly partners with federal agencies like NIAID on research and clinical trial activities related to infectious diseases, public health, and other biomedical areas.
Quick answers
Who was awarded contract HHSN27200017?
HHSN27200017 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 27, 2016.
How much is contract HHSN27200017 worth?
The government has obligated $1,468,838 on HHSN27200017. Its potential value, with all options, is $1,771,856.
Is contract HHSN27200017 an order under another contract?
Yes. HHSN27200017 is a delivery order under HHSN272201300022I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract HHSN27200017 competed?
The extent of competition for HHSN27200017 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award